— Know what they know.
Not Investment Advice

VYNE NASDAQ

VYNE Therapeutics Inc.
1W: -28.6% 1M: +4282.4% 3M: +4327.2% YTD: +4825.0% 1Y: +2031.3% 3Y: +556.5% 5Y: -42.3%
$28.56
Last traded 2026-07-27 — delisted
NASDAQ · Healthcare · Biotechnology · $19.1M mcap · 613692 float · 4.11% daily turnover · Short 31% of daily vol

No ESG data available for VYNE

ESG scores are derived from SEC filings (10-K, 10-Q) and may not be available for all companies.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms